Gene · 10818
Papers1,537
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,537
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CDK4 is co-amplified with either TP53 promoter gene fusions or MDM2 through distinct mechanisms in osteosarcoma. | NPJ Genom Med | 2024 | 39322633 | PubTator, text mining | PubMed |
| Targeting the cancer cells and cancer-associated fibroblasts with next-generation FGFR inhibitors in prostate cancer co-culture models. | Cancer Med | 2024 | 39300962 | PubTator, text mining | PubMed |
| A molecular epidemiological and transmission analysis of Clostridioides difficile using draft whole-genome sequencing in a single hospital. | BMC Infect Dis | 2024 | 39289598 | PubTator, text mining | PubMed |
| Hsa_circ_0007765 Promotes Platelet-Derived Growth Factor-BB-Induced Proliferation and Migration of Human Aortic Vascular Smooth Muscle Cells in Atherosclerosis. | Cardiovasc Toxicol | 2024 | 39126580 | PubTator, text mining | PubMed |
| Macrophage-derived FGFR1 drives atherosclerosis through PLCγ-mediated activation of NF-κB inflammatory signalling pathway. | Cardiovasc Res | 2024 | 38842387 | PubTator, text mining | PubMed |
| The combination of gemcitabine plus an anti-FGFR inhibitor can have a synergistic antitumor effect on FGF-activating cholangiocarcinoma. | Cancer Lett | 2024 | 38801887 | PubTator, text mining | PubMed |
| IFDlong: an isoform and fusion detector for accurate annotation and quantification of long-read RNA-seq data. | bioRxiv | 2024 | 38798496 | PubTator, text mining | PubMed |
| Ligand bias underlies differential signaling of multiple FGFs via FGFR1. | Elife | 2024 | 38568193 | PubTator, text mining | PubMed |
| Vestibulospinal reflexes elicited with a tone burst method are dependent on spatial orientation. | PeerJ | 2024 | 38436036 | PubTator, text mining | PubMed |
| FGF9, a Potent Mitogen, Is a New Ligand for Integrin αvβ3, and the FGF9 Mutant Defective in Integrin Binding Acts as an Antagonist. | Cells | 2024 | 38391921 | PubTator, text mining | PubMed |
| Hsa_circ_0032389 Enhances Proliferation and Migration in PDGF-BB-Induced Human Aortic Vascular Smooth Muscle Cells. | Cardiovasc Toxicol | 2024 | 38378972 | PubTator, text mining | PubMed |
| Circ_0004872 deficiency attenuates ox-LDL-induced vascular smooth muscle cell dysfunction by miR-424-5p-dependent regulation of FRS2. | Mol Cell Biochem | 2024 | 38376663 | PubTator, text mining | PubMed |
| Activated FGFR2 signalling as a biomarker for selection of intrahepatic cholangiocarcinoma patients candidate to FGFR targeted therapies. | Sci Rep | 2024 | 38326380 | PubTator, text mining | PubMed |
| Molecular Targeting of the Fibroblast Growth Factor Receptor Pathway across Various Cancers. | Int J Mol Sci | 2024 | 38255923 | PubTator, text mining | PubMed |
| Genetic, Epigenetic and Transcriptome Alterations in Liposarcoma for Target Therapy Selection. | Cancers (Basel) | 2024 | 38254762 | PubTator, text mining | PubMed |
| Death Induced by Survival gene Elimination (DISE) correlates with neurotoxicity in Alzheimer's disease and aging. | Nat Commun | 2024 | 38238311 | PubTator, text mining | PubMed |
| A primary pulmonary artery sarcoma masquerading pulmonary embolism: a case report and literature review. | Thromb J | 2024 | 38178144 | PubTator, text mining | PubMed |
| FRS2 regulated by miR-429 and miR-206 promotes angiogenesis in osteosarcoma. | Gene | 2024 | 38159618 | PubTator, text mining | PubMed |
| Landscape of Clinical Resistance Mechanisms to FGFR Inhibitors in FGFR2-Altered Cholangiocarcinoma. | Clin Cancer Res | 2024 | 37843855 | PubTator, text mining | PubMed |
| Effective fraction of Gualou-Xiebai-Banxia decoction inhibits the apoptosis of myocardial cells induced by ox-LDL via FGF21/FGFR1/βKlotho-FRS2α signal pathway. | J Ethnopharmacol | 2024 | 37595815 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10818/papers?page=3